You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The closing range uses available history since Oct 27, 2026; less than a full year is stored.
Indoco Remedies reported Q2 FY27 consolidated net revenue of Rs. 5,069 million, up 7.4%, with consolidated EBITDA of Rs. 464 million at 9.2% of net sales. International formulation revenue grew 12.1% to Rs. 1,720 million.
Illustrative technical + ownership context — a signal mix, not investment advice.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XBOM:INDOCO | +5.7% | — | — | +9.6% | — |
No verified company website is available for this listing yet.
Share classes and depositary receipts can have different prices and dividends.
| Ex-dividend date | Amount per share |
|---|---|
| 2026-09-10 | 0.20 INR |
| 2025-09-04 | 0.20 INR |
| 2024-09-19 | 1.50 INR |
| 2023-09-18 | 2.25 INR |
| 2022-09-14 | 2.25 INR |
| 2021-09-17 | 1.50 INR |
| 2020-09-18 | 0.30 INR |
| 2019-08-22 | 0.30 INR |
| 2018-08-31 | 1.00 INR |
| 2017-07-31 | 1.60 INR |
| 2016-07-20 | 0.20 INR |
| 2016-03-17 | 1.40 INR |
| 2015-07-21 | 1.60 INR |
| 2014-07-21 | 1.40 INR |
| 2013-07-19 | 1.10 INR |
| 2012-07-20 | 1.10 INR |
No upcoming investor events are listed for this company yet.
